UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 86

Sortiert nach

Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study

The Lancet (British edition), 2020-08, Vol.396 (10251), p.603-611

2020

Volltextzugriff (PDF)

Whole blood immunophenotyping uncovers immature neutrophil-to-VD2 T-cell ratio as an early marker for severe COVID-19

Nature communications, 2020-10, Vol.11 (1), p.5243-5243, Article 5243

2020

Volltextzugriff (PDF)

Convalescent COVID-19 patients are susceptible to endothelial dysfunction due to persistent immune activation

eLife, 2021-03, Vol.10

2021

Volltextzugriff (PDF)

Linear B-cell epitopes in the spike and nucleocapsid proteins as markers of SARS-CoV-2 exposure and disease severity

EBioMedicine, 2020-08, Vol.58, p.102911, Article 102911

2020

Volltextzugriff (PDF)

Pathogenic Th1 responses in CHIKV‐induced inflammation and their modulation upon Plasmodium parasites co‐infection

Immunological reviews, 2020-03, Vol.294 (1), p.80-91

2020

Volltextzugriff (PDF)

Asymptomatic COVID‐19: disease tolerance with efficient anti‐viral immunity against SARS‐CoV‐2

EMBO molecular medicine, 2021-06, Vol.13 (6), p.e14045-n/a

2021

Volltextzugriff (PDF)

Prolonged inflammation in patients hospitalized for coronavirus disease 2019 (COVID‐19) resolves 2 years after infection

Journal of medical virology, 2023-05, Vol.95 (5), p.e28774-n/a

2023

Volltextzugriff (PDF)

The association of hypertension and diabetes pharmacotherapy with COVID-19 severity and immune signatures: an observational study

European heart journal. Cardiovascular pharmacotherapy, 2021-05, Vol.7 (3), p.e48-e51

2021

Volltextzugriff (PDF)

Age has a role in driving host immunopathological response to alphavirus infection

Immunology, 2017-12, Vol.152 (4), p.545-555

2017

Volltextzugriff (PDF)

Plasmodium co-infection protects against chikungunya virus-induced pathologies

Nature communications, 2018-09, Vol.9 (1), p.3905-13, Article 3905

2018

Volltextzugriff (PDF)

Role of T Cells in Chikungunya Virus Infection and Utilizing Their Potential in Anti-Viral Immunity

Frontiers in immunology, 2020-02, Vol.11, p.287-287

2020

Volltextzugriff (PDF)

Robust Virus-Specific Adaptive Immunity in COVID-19 Patients with SARS-CoV-2 Δ382 Variant Infection

Journal of clinical immunology, 2022-02, Vol.42 (2), p.214-229

2022

Volltextzugriff (PDF)

Near‐Infrared and Visible Dual‐Emitting Peptide by Modular Assembly of Nitrobenzoxadiazole and Neodymium Complexes

Advanced optical materials, 2024-03, Vol.12 (9), p.n/a

2024

Volltextzugriff (PDF)

Mutating chikungunya virus non‐structural protein produces potent live‐attenuated vaccine candidate

EMBO molecular medicine, 2019-06, Vol.11 (6), p.n/a

2019

Volltextzugriff (PDF)

VCP/p97 Is a Proviral Host Factor for Replication of Chikungunya Virus and Other Alphaviruses

Frontiers in microbiology, 2019-09, Vol.10, p.2236-2236

2019

Volltextzugriff (PDF)

Two-stage approach to intracranial hemorrhage segmentation from head CT images

IEEE access, 2024-01, Vol.12, p.1-1

2024

Volltextzugriff (PDF)

Differential Cytokine Responses in Hospitalized COVID-19 Patients Limit Efficacy of Remdesivir

Frontiers in immunology, 2021-06, Vol.12, p.680188-680188

2021

Volltextzugriff (PDF)

Associations of viral ribonucleic acid (RNA) shedding patterns with clinical illness and immune responses in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2) infection

Clinical & translational immunology, 2020, Vol.9 (7), p.e1160-n/a

2020

Volltextzugriff (PDF)

Correction to: Robust Virus‐Specific Adaptive Immunity in COVID‐19 Patients with SARS‐CoV‐2 Δ382 Variant Infection

Journal of clinical immunology, 2022-02, Vol.42 (2), p.230-231

2022

Volltextzugriff (PDF)

Safety and potential efficacy of cyclooxygenase‐2 inhibitors in coronavirus disease 2019

Clinical & translational immunology, 2020, Vol.9 (7), p.e1159-n/a

2020

Volltextzugriff (PDF)

Longitudinal [18F]FB-IL-2 PET Imaging to Assess the Immunopathogenicity of O'nyong-nyong Virus Infection

Frontiers in immunology, 2020-05, Vol.11, p.894-894

2020

Volltextzugriff (PDF)

Resistance of SARS-CoV-2 Delta variant to neutralization by BNT162b2-elicited antibodies in Asians

The Lancet regional health. Western Pacific, 2021-10, Vol.15, p.100276-100276, Article 100276

2021

Volltextzugriff (PDF)

Fever Patterns, Cytokine Profiles, and Outcomes in COVID-19

Open forum infectious diseases, 2020-09, Vol.7 (9), p.ofaa375-ofaa375

2020

Volltextzugriff (PDF)

1 – 25 von 86

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(79)
Mit Volltextzugriff
(79)

Publikationsform

Sprache

Englisch
(86)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Science & Technology
(71)
Life Sciences & Biomedicine
(54)
Humans
(32)
Covid-19
(19)
Animals
(15)
Immunology
(14)
Sars-Cov-2
(14)
Coronaviruses
(12)
Infections
(12)
Inflammation
(12)
Technology
(12)
Cytokines
(11)
Female
(11)
Patients
(11)
Male
(10)
Severe Acute Respiratory Syndrome Coronavirus 2
(9)
Computer Science
(8)
Engineering
(8)
Medicine, Research & Experimental
(8)
Research & Experimental Medicine
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study

Whole blood immunophenotyping uncovers immature neutrophil-to-VD2 T-cell ratio as an early marker for severe COVID-19

Convalescent COVID-19 patients are susceptible to endothelial dysfunction due to persistent immune activation

Linear B-cell epitopes in the spike and nucleocapsid proteins as markers of SARS-CoV-2 exposure and disease severity

Pathogenic Th1 responses in CHIKV‐induced inflammation and their modulation upon Plasmodium parasites co‐infection

Decreased memory B cell frequencies in COVID‐19 delta variant vaccine breakthrough infection

Asymptomatic COVID‐19: disease tolerance with efficient anti‐viral immunity against SARS‐CoV‐2

Prolonged inflammation in patients hospitalized for coronavirus disease 2019 (COVID‐19) resolves 2 years after infection

The association of hypertension and diabetes pharmacotherapy with COVID-19 severity and immune signatures: an observational study

Age has a role in driving host immunopathological response to alphavirus infection

Plasmodium co-infection protects against chikungunya virus-induced pathologies

Role of T Cells in Chikungunya Virus Infection and Utilizing Their Potential in Anti-Viral Immunity

Robust Virus-Specific Adaptive Immunity in COVID-19 Patients with SARS-CoV-2 Δ382 Variant Infection

Near‐Infrared and Visible Dual‐Emitting Peptide by Modular Assembly of Nitrobenzoxadiazole and Neodymium Complexes

Mutating chikungunya virus non‐structural protein produces potent live‐attenuated vaccine candidate

VCP/p97 Is a Proviral Host Factor for Replication of Chikungunya Virus and Other Alphaviruses

Two-stage approach to intracranial hemorrhage segmentation from head CT images

Differential Cytokine Responses in Hospitalized COVID-19 Patients Limit Efficacy of Remdesivir

Associations of viral ribonucleic acid (RNA) shedding patterns with clinical illness and immune responses in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2) infection

Correction to: Robust Virus‐Specific Adaptive Immunity in COVID‐19 Patients with SARS‐CoV‐2 Δ382 Variant Infection

Data-Driven Analysis of COVID-19 Reveals Persistent Immune Abnormalities in Convalescent Severe Individuals

Safety and potential efficacy of cyclooxygenase‐2 inhibitors in coronavirus disease 2019

Longitudinal [18F]FB-IL-2 PET Imaging to Assess the Immunopathogenicity of O'nyong-nyong Virus Infection

Resistance of SARS-CoV-2 Delta variant to neutralization by BNT162b2-elicited antibodies in Asians

Fever Patterns, Cytokine Profiles, and Outcomes in COVID-19

Suchergebnisse filtern